Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 23 clinical trials
Featured trial
CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.

CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.

  • 144 views
  • 08 Nov, 2020
  • 1 location
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

  • 0 views
  • 23 Apr, 2022
  • 1 location
Adjuvant FOLFOXIRI for High-risk Stage III Colon Cancer

A multicenter, open labeled randomized, phase II trial comparing FOLFOXIRI and mFOLFOX6 as adjuvant treatment for high risk stage III (pT4N1/2 or pTanyN2) colon cancer

  • 0 views
  • 26 Mar, 2022
  • 1 location
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

BACKGROUND In patients with high risk stage II and stage III colon cancer (CC), curative surgery followed by adjuvant chemotherapy with FOLFOX or CAPOX regimens

  • 0 views
  • 23 Mar, 2022
  • 1 location
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and

hysterectomy
stage iii colon cancer
adenocarcinoma
tumor cells
antibiotics
  • 1145 views
  • 21 Oct, 2022
  • 545 locations
A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients With High-Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial (CHALLENGE)

alone for patients who have undergone treatment for high-risk stage II or stage III colon cancer.

fatigue assessment and management
colon cancer
fatigue
immunomodulators
x-rays
  • 598 views
  • 22 Oct, 2022
  • 47 locations
  • 0 views
  • 10 Oct, 2022
  • 41 locations
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting (IROCAS)

, folinic acid, 5-FU (mFOLFOX 6) chemotherapy protocols in patients with high-risk stage III colon cancer in the adjuvant setting.

  • 116 views
  • 04 Oct, 2022
  • 8 locations
Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over (ADAGE)

chemotherapy has demonstrated a benefit on disease-free survival and overall survival after a stage III colon cancer resection. Nevertheless adjuvant chemotherapy is poorly used in elderly patients. Prognostic

oxaliplatin
stage iii colon cancer
primary tumor
capecitabine
fluoropyrimidine
  • 31 views
  • 07 Apr, 2022
  • 137 locations
Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer (CTAC)

The IDEA study classified stage III colon cancer into low-risk (T1-3/N1) and high-risk patients (T4 or N2) according to TNM stage. The results showed that for some low-risk patients

  • 0 views
  • 07 Oct, 2022
  • 1 location